• KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy

    Tuesday January 16th 2024

  • Health & care incubator BioVille strengthens its position with additional 2,000m² wing

    Tuesday January 16th 2024

  • Aphea.Bio welcomes Hadyn Parry as Chairman of its Board: propelling the company's vision for sustainable agriculture

    Wednesday January 10th 2024

  • Researchers map cell composition of metastatic melanoma and identify cause of immunotherapy resistance

    Tuesday January 9th 2024

  • From goblet cells to gut health: the role of AGR2 and mucus

    Monday January 8th 2024

  • Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

    Friday January 5th 2024

  • Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology

    Thursday January 4th 2024

  • Sequana Medical granted US CPT® III reimbursement codes for alfapump® system

    Wednesday January 3rd 2024

  • Your news here?

  • George Hutchinson joins FOx BIOSYSTEMS as VP Global Sales

    Tuesday January 2nd 2024

  • Galapagos signs agreement to transfer Jyseleca® business to Alfasigma

    Tuesday January 2nd 2024

  • Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

    Thursday December 28th 2023

Strategic Partners